Menarini's Orserdu 'first and only' breast cancer therapy of its kind approved by European Commission 21-Sep-2023 By Liza Laws The European Commission has approved the Menarini Group’s Orsedu (elacestrant) as a monotherapy for the treatment of postmenopausal women and men with breast cancer.